Stealth Viruses:
Nature's Biological Weapons Program
W. John Martin, M.D, Ph.D., Founder, CCID
Center For Complex Infectious Disease Website: www.ccid.org
Man
has evolved in constant competition with disease causing microbes. Major
epidemics of rapidly developing, easily identifiable infectious illnesses have
occurred throughout history, leading to major losses of human life. Examples
include the Black Plagues of the Middle Ages and the 1919 worldwide outbreak of
Influenza. Less rapidly evolving human infections, such as the progressive
destruction of the immune system by human immunodeficiency virus (HIV), were
slower to be recognized by healthcare providers.
A small but growing segment of society has expressed concerns that many forms
of neuropsychiatric, autoimmune, metabolic, and malignant diseases may also be
infectious in nature. My reports to the Centers for Disease Control and
Prevention (CDC) of the isolation of atypical, structurally-modified,
cell-damaging viruses from patients with these illnesses are currently under
consideration. At issue is my contention that some of these
atypically-structured viruses most probably arose from contaminants of live
viral vaccines. One such virus has retained several genes that closely match to
segments of the Cytomegalovirus of African green monkeys. These monkeys were
used until recently for the production of live poliovirus vaccines within the
United States, and are still being used for polio vaccines administered under
the auspices of the World Health Organization.
The modified African green monkey simian Cytomegalovirus (SCMV) failed to evoke
an inflammatory response within the patient from which it has been repeatedly
isolated, or from animals developing widespread illness following injection of
the virus. Unlike HIV, which destroys the immune system, this virus simply
evades effective immune recognition.
The immune system protects against normal, typical viruses
by reacting to only a few of the many different components coded by viral
genes. Deletion or mutation of these few critical genes can lead to a
"stealth-adapted" virus that is essentially hidden from our
anti-viral cellular immune defenses. The process of stealth adaptation can
involve more that just the elimination of a few viral genes. Detailed, ongoing
DNA sequencing studies on the SCMV-derived stealth-adapted virus has shown an
uncanny ability to assimilate and to mutate various additional genetic
elements. Some of these additional genes are derived from cellular genes, and
include genetic sequences of potential cancer-forming capacity. Others are of
bacterial origins, and indicate the capacity of the virus to breach the
long-standing barrier that has previously separated nucleated (eukaryotic)
animal and plant cells from non-nucleated (prokaryotic) bacteria. These
provocative findings define new ways in which viruses can be constructed and
transmitted. While some stealth-adapted viruses almost certainly arose from vaccines,
others may simply reflect the capacity of Nature to recombine pieces of genetic
information in ingenious ways. Possibly she has succeeded way beyond the
capacity of those in the military or in various terrorist groups to manufacture
biological weapons.
Without waiting for CDC to act, the Center for Complex Infectious Diseases is
proceeding with expanded studies on these viruses and on those infected. CCID
is in the process of recruiting paid and voluntary involvement of clinicians,
researchers and administrators to join in a nationwide effort to confront this
hidden epidemic.
Inquires can be addressed to:
CCID at 3328 Stevens Avenue, Rosemead CA 91770.
Phone 626 572-7288
Fax 626 572-9288
e-mail stealthvirus@mail.com
Additional information concerning stealth viruses and CCID
is accessible at http://www.stealthvirus.com
